Drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain, an international study reports, for the first time.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1FhdXfM
from Today's Healthcare News -- ScienceDaily http://ift.tt/1FhdXfM
No comments:
Post a Comment